Iovance Biotherapeutics Inc
NASDAQ:IOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
US |
|
US Gold Corp
NASDAQ:USAU
|
US |
|
Sa Sa International Holdings Ltd
HKEX:178
|
HK |
|
F
|
Facilities By ADF PLC
LSE:ADF
|
UK |
|
K
|
Kohls Corp
DUS:KHP
|
US |
|
AML3D Ltd
ASX:AL3
|
AU |
|
Maxim Power Corp
TSX:MXG
|
CA |
|
Barratt Developments P L C
OTC:BTDPF
|
UK |
|
L
|
LifeMD Inc
NASDAQ:LFMD
|
US |
|
Yadea Group Holdings Ltd
HKEX:1585
|
CN |
|
Wavefront Technology Solutions Inc
XTSX:WEE
|
CA |
|
Arrow Electronics Inc
NYSE:ARW
|
US |
|
Anmol India Ltd
NSE:ANMOL
|
IN |
|
Banco Santander SA
MAD:SAN
|
ES |
Wall St Price Targets
IOVA Price Targets Summary
Iovance Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for
IOVA is 8.84 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IOVA's stock price target?
Price Target
8.84
USD
According to Wall Street analysts, the average 1-year price target for
IOVA is 8.84 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
28%
The compound annual growth rate for Revenue over the next 8 years is 28%.